Clinical trials
Phase 2 Glomerulonephritis, IGA trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 10 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Vera Therapeutics, Inc. | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Travere Therapeutics, Inc. | 2 |
| ADARx Pharmaceuticals, Inc. | 1 |
| Akebia Therapeutics | 1 |
| Amgen | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Aravive, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 30 |
| Kidney Diseases | 7 |
| Glomerulonephritis | 6 |
| Lupus Nephritis | 5 |
| Proteinuria | 5 |
| Urologic Diseases | 4 |
| Autoimmune Diseases | 3 |
| Diabetic Nephropathies | 3 |
| Glomerulosclerosis, Focal Segmental | 3 |
| Immune System Diseases | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.